Communicate With Your Partner: Open conversations about changes in libido can strengthen intimacy and create a supportive environment for reconnecting
Novartis Pharmaceuticals added a Yardley site to NCT07517263, the open-label long-term extension study for pelacarsen (TQJ230), which targets lipoprotein(a)-driven cardiovascular disease
Your weight loss typically resumes within 4 weeks if the semaglutide dose is optimal for your body
For researchers comparing tirzepatide to structurally simpler peptides in their work, the injectable vs oral peptides comparison provides context on how molecular complexity affects formulation options
Ozempic and drugs like it, including Wegovy, Monjouro, and Zepbound, have been praised as game-changing medications for weight loss in qualified patients
In patients with clinical evidence or subclinical evidence of CV disease and who received standard of care for T2DM, treatment with either dose of SEM for 30 weeks was associated with greater glycemic control, compared with placebo